ClinicalTrialsFinder

Paroxysmal Nocturnal Hemoglobinuria, PNH Clinical Trials in Toronto, Ontario

1 recruitingToronto, Ontario, Canada

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

A First-in-Human Safety and Efficacy Study of ALN-CFB, a Small Interfering RNA (siRNA) Targeting Complement Factor B, in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria With Persistent Anemia on a C5 Inhibitor

Paroxysmal Nocturnal Hemoglobinuria, PNHPersistent Anemia
Regeneron Pharmaceuticals24 enrolled7 locationsNCT07187401